Most cancer centers and hospitals with strong cancer programs were rated in the "A" range by Moody, a global provider of credit ratings and risk assessment.
Moody's Investors Service is a leading global provider of credit ratings, research and risk analysis. It assigned rating scores to some of the top cancer centers and hospitals. Ratings are determined by the financial well-being of the organization, ranging from "Aaa" to "C." "A" ratings indicate quality investments with low risks. Read more about the rating methodology here.
Here are 11 cancer centers and hospitals with top ranked cancer programs by U.S. News with their Moody ratings:
Note: Ratings were taken from the last available documents, which range from 2018 to 2023 release dates.
Beth Israel Lahey Health, based in Cambridge, Mass., received an "A3" rating and a stable outlook.
Cedars-Sinai Health System, based in Los Angeles, received a "Aa3" rating and a stable outlook.
City of Hope, based in Los Angeles, received an "A3" rating and stable outlook.
Dana-Farber Cancer Institute, based in Boston, received an "A1" rating and a stable outlook.
Fred Hutchinson Cancer Center, based in Seattle, received an "A2" rating and a stable outlook.
H. Lee Moffitt Cancer Center, based in Tampa, Fla., received a "A2" rating and a stable outlook.
Johns Hopkins Health System, based in Baltimore, received an "Aa3" rating and a positive outlook.
Mayo Clinic, based in Rochester, Minn., received a "Aa2" rating and a stable outlook.
Memorial Sloan Kettering Cancer Center, based in New York City, received an "Aa3" rating and a stable outlook.
Mount Sinai Tisch Cancer Center, based in New York City, received a "Baa1" rating and a stable outlook.
NewYork-Presbyterian Hospital, based in New York City, received an "Aa2" rating and a stable outlook.